Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The salvage regimen for patients with advanced non-small cell lung cancer who failed prior chemotherapy: once-daily single oral agent Iressa].
Zheng D, Yamadori T, Hirashima T, Uryu K, Matui K, Nitta T, Kobayashi M, Sasada S, Takimoto N, Furukawa M, Ooba Y, Zhou C. Zheng D, et al. Among authors: kobayashi m. Zhongguo Fei Ai Za Zhi. 2004 Aug 20;7(4):313-7. doi: 10.3779/j.issn.1009-3419.2004.04.10. Zhongguo Fei Ai Za Zhi. 2004. PMID: 21241549 Free article. Chinese.
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Tamiya M, Kobayashi M, Morimura O, Yasue T, Nakasuji T, Satomu M, Kohei O, Takayuki S, Morishita N, Suzuki H, Sasada S, Okamoto N, Hirashima T, Kawase I. Tamiya M, et al. Among authors: kobayashi m. Clin Lung Cancer. 2013 Jan;14(1):50-4. doi: 10.1016/j.cllc.2012.03.012. Epub 2012 May 18. Clin Lung Cancer. 2013. PMID: 22609050
A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.
Matsui K, Hirashima T, Nitta T, Kobayashi M, Ogata Y, Furukawa M, Kudoh S, Yoshimura N, Mukohara T, Yamauchi S, Shiraishi S, Kamoi H, Negoro S, Takeda K, Nakagawa K, Takada M, Yana T, Fukuoka M. Matsui K, et al. Among authors: kobayashi m. Jpn J Clin Oncol. 2005 Apr;35(4):181-7. doi: 10.1093/jjco/hyi057. Jpn J Clin Oncol. 2005. PMID: 15845566 Clinical Trial.
Efficacy of carboplatin and paclitaxel with bevacizumab as salvage chemotherapy for non-small cell lung cancer after failure of platinum-doublet chemotherapy.
Tamiya M, Tamiya A, Nakao K, Asami K, Okishio K, Satomu M, Shiroyama T, Morishita N, Suzuki H, Sasada S, Okamoto N, Okishio K, Kawaguchi T, Kobayashi M, Atagi S, Hirashima T, Kawase I. Tamiya M, et al. Among authors: kobayashi m. Anticancer Res. 2012 Aug;32(8):3553-7. Anticancer Res. 2012. PMID: 22843945
Prognosis of small-cell lung cancer since the introduction of amrubicin.
Suzuki H, Hirashima T, Kobayashi M, Sasada S, Okamoto N, Tamiya M, Matsuura Y, Morishita N, Uehara N, Matsui K, Kawase I. Suzuki H, et al. Among authors: kobayashi m. Med Oncol. 2011 Dec;28(4):1430-5. doi: 10.1007/s12032-010-9623-z. Epub 2010 Jul 15. Med Oncol. 2011. PMID: 20632217
Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions.
Sasada S, Hirashima T, Nakamura Y, Takimoto T, Furukawa M, Kobayashi M, Nitta T, Matsui K, Kawase I. Sasada S, et al. Among authors: kobayashi m. Int J Clin Oncol. 2007 Aug;12(4):274-8. doi: 10.1007/s10147-007-0675-9. Epub 2007 Aug 20. Int J Clin Oncol. 2007. PMID: 17701006
12,160 results
You have reached the last available page of results. Please see the User Guide for more information.